Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Income Statement [Abstract] | ||||
| SALES | $ 659,881 | $ 813,951 | $ 2,460,218 | $ 1,743,226 |
| COST OF SALES (excluding depreciation expense) | 381,773 | 346,611 | 1,268,661 | 801,042 |
| GROSS PROFIT | 278,108 | 467,340 | 1,191,557 | 942,184 |
| OPERATING EXPENSES: | ||||
| Compensation and related benefits | (403,517) | (308,991) | (1,556,184) | (1,177,044) |
| Professional fees | (86,814) | (111,005) | (316,428) | (491,958) |
| General and administrative expenses | (150,836) | (161,975) | (515,884) | (483,279) |
| Total Operating Expenses | (641,167) | (581,971) | (2,388,496) | (2,152,281) |
| OTHER OPERATING INCOME: | ||||
| Gain on sale of product line | 4,051,709 | |||
| (LOSS) INCOME FROM OPERATIONS | (363,059) | (114,631) | (1,196,939) | 2,841,612 |
| OTHER INCOME (EXPENSES): | ||||
| (Loss) gain on debt extinguishment, net | (221,220) | 9,250 | 126,770 | 471,831 |
| Interest expense | (88,450) | (58,301) | (156,177) | (420,276) |
| Interest expense - related party | (386) | (6,049) | ||
| Total Other Income (Expenses), net | (309,670) | (49,437) | (29,407) | 45,506 |
| NET (LOSS) INCOME BEFORE NONCONTROLLING INTEREST | (672,729) | (164,068) | (1,226,346) | 2,887,118 |
| Net (income) loss of subsidiary attributable to noncontrolling interest | 36,524 | (28,657) | 22,807 | 6,705 |
| Preferred stock dividend | (11,008) | (13,483) | (39,106) | (40,788) |
| NET (LOSS) INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS | $ (647,213) | $ (206,208) | $ (1,242,645) | $ 2,853,035 |
| NET (LOSS) INCOME PER COMMON SHARE: | ||||
| Basic (in Dollars per share) | $ 0 | $ 0 | $ 0 | $ 0.01 |
| Diluted (in Dollars per share) | $ 0 | $ 0 | $ 0 | $ 0 |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||||
| Basic (in Shares) | 545,253,623 | 524,747,583 | 541,386,297 | 478,703,698 |
| Diluted (in Shares) | 545,253,623 | 524,747,583 | 541,386,297 | 2,355,294,011 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expenses related to the generation of investment income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
